FILTER
FILTERED INTERVIEW RESULTS
Fabrice Panza
MANAGER GLOBAL COOL CHAIN SOLUTIONS, ETIHAD CARGO
"Etihad Cargo’s PharmaLife product has exponentially grown over the past year, and growth will trigger more physical ties between US and UAE."
Dagny Odell
OWNER, PRACTICAL MINING
"If you think about the end use and reclamation requirements early on and incorporate solutions early, it makes the project much more efficient and improves the final environmental outcome."
Mark Compton
EXECUTIVE DIRECTOR, AMERICAN EXPLORATION & MINING ASSOCIATION (AEMA)
"Put simply, without permitting reform it will be impossible to meet our nation’s mineral needs."
James Sapirstein
CHAIRMAN, PRESIDENT, AND CEO, FIRST WAVE BIOPHARMA
“We are happy to report that we have initiated the Phase 2 SPAN adrulipase clinical and are currently screening patients for the study. We anticipate topline data by mid-2023.”
Kendalle O’Connell
CEO AND PRESIDENT, MASSBIO
"In 2022, Massachusetts received 25% of all biopharma VC funding in the US. We are seeing new clusters emerge outside the traditional hubs of Kendall Square and Boston."
Arda Ural
AMERICAS INDUSTRY MARKET LEADER, HEALTH SCIENCES & WELLNESS, EY USA
"We are going to help the industry digitalize, prepare for the innovation deficit due to expiring patents and improve strategies that lead to better M&A opportunities."
Eric J. Mears
VICE PRESIDENT, HALEY & ALDRICH
"Arizona currently uses as much water now as it did in the mid 1950’s. Conservation, water banking, and forward-looking water laws have played a tremendous role in this."
Darryl Sockwell & Michael Judd
WEST COAST DIVISION DISTRICT MANAGER (DS) & WEST COAST DIVISION BUSINESS DEVELOPMENT MANAGER (MJ), MMR CONSTRUCTORS
“We have tremendous growth opportunities, particularly in the western region where many of the larger mines are located. The schedule and demand in the mining sector is aggressive and I don’t see it slowing down anytime soon.”
David Schaffer
EXECUTIVE DIRECTOR, QB3
"The Bay Area offers a confluence of universities, investors and companies, and we are interested in strengthening bridges between these institutions to streamline the process of technology translation."
Mark A. Goldberg
CEO, ALLUCENT
"Given that a significant amount of intellectual property and cutting-edge science resides within smaller companies, we created a purpose-built firm to help smaller players develop their products and bring them to market."
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
